Scarica l'app Stockscreener
3.20
3.03%
-0.10
Dopo l'orario di chiusura:
3.12
-0.08
-2.50%
Heartsciences Inc Borsa (HSCS) Ultime notizie
Lifestyle Icon Martha Stewart Confirmed As Vivid Sydney 2025's Global Storyteller - Barchart.com
This AI Company Is Solving A 100+ Year-Old Health Problem - Barchart.com
Eagle Eye Appoints Chief Revenue Officer, Jeff Baskin, to Accelerate Growth in North America - Barchart.com
/R E P E A T -- LASSONDE INDUSTRIES INC. WILL HOLD A CONFERENCE CALL TO DISCUSS ITS Q4 AND FISCAL 2024 RESULTS/ - Barchart.com
HeartSciences faces Nasdaq delisting over equity shortfall By Investing.com - Investing.com Canada
HeartSciences faces Nasdaq delisting over equity shortfall - Investing.com
12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga
HeartSciences Provides Business Update and Reports Third Quarter Fiscal 2025 Financial Results - The Manila Times
HeartSciences Reports Third Quarter Fiscal 2025 Financial Results and Business Update on AI-Powered ECG Innovations - Nasdaq
HeartSciences Q3: AI-ECG Breakthrough Nears FDA Milestone as CMS Backs Reimbursement - StockTitan
12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga
HeartSciences Inc. Engages Integrous Communications to Enhance Investor Communications - The Manila Times
AI Medical Tech Firm HeartSciences Strengthens Investor Communications Strategy - StockTitan
HeartSciences grants stock options to executives and directors - MSN
HeartSciences grants stock options to executives and directors By Investing.com - Investing.com South Africa
Becton, Dickinson And Company's Q1 2025 Earnings: What To Expect - Barchart.com
Scientists Discover Heart-Saving Powers in Olive, Grape, Garlic, Rosemary, and Saffron - SciTechDaily
HeartSciences Inc. withdraws IPO registration - Investing.com
HeartSciences Inc. withdraws IPO registration By Investing.com - Investing.com UK
Biogen Stock: Is BIIB Underperforming The Healthcare Sector? - Barchart.com
HeartSciences Provides Business Update and Reports Second Quarter Fiscal 2025 Financial Results - The Manila Times
HeartSciences Advances AI-Powered ECG Platform, FDA Submission Set for Q1 2025 - StockTitan
Anteris Technologies Prices $88.8M Nasdaq IPO for Revolutionary Heart Valve Development - StockTitan
Bill Otten Joins Hello Heart as Commercial President - Medical Product Outsourcing
David Chung Lands Top Job at Heart Repair Technologies - Medical Product Outsourcing
HeartSciences' AI-ECG Algorithms Assigned CMS Medicare and Medicaid Reimbursement - The Manila Times
HeartSciences’ AI-ECG Algorithms Assigned CMS Medicare and Medicaid Reimbursement - GlobeNewswire
HeartSciences Secures $125 Medicare Reimbursement for AI-ECG Tech, Awaits FDA Nod | HSCSW Stock News - StockTitan
HeartSciences shareholders approve auditor and meeting adjournment - Investing.com India
HeartSciences shareholders approve auditor and meeting adjournment By Investing.com - Investing.com UK
Clear Secure: Q3 Earnings Snapshot - Barchart.com
Investor Alert: Halo Collective, Inc. And Its Missing Continuous Disclosure Documents - Barchart.com
Heart Test Laboratories announces corporate name change to HeartSciences - Investing.com India
What To Expect From Pfizer's Q3 2024 Earnings Report - Barchart.com
HeartSciences to Participate in the 2024 Maxim Healthcare Virtual Summit - The Manila Times
Earnings Preview: What To Expect From Intuitive Surgical's Report - Barchart.com
3 Penny Stocks to Watch Now, 9/25/24 - MSN
Why Maison Solutions Shares Are Trading Higher By Around 91%; Here Are 20 Stocks Moving Premarket - Benzinga
Shares of HeartSciences get a bump from announcement of non-dilutive financing - Kursiv Media
HeartSciences Provides Business Update and Reports First Quarter Fiscal 2025 Financial Results - GlobeNewswire
HeartSciences reports fiscal 2024 financial results - Medical Buyer
Innovation Value Institute Analysis Demonstrates HeartSciences’ MyoVista® wavECG™ Potential to Improve Cardiovascular Pathway Efficiency - GlobeNewswire
HeartSciences Selected to Demonstrate MyoVista® wavECG™ at the United Nations General Assembly Digital Health Symposium as a Technology to Radically Transform Healthcare - GlobeNewswire
HeartSciences Adds Another International Patent to its IP Portfolio - MPO-mag
HeartSciences Announces Allowance of U.S Patent for AI-ECG Assessment of Left Ventricular and Right Ventricular Heart Dysfunction - Diagnostic and Interventional Cardiology
Alexandria Real Estate Equities, Inc. Releases 2023 Corporate Responsibility Report Highlighting Its Longstanding Leadership at the Vanguard and Heart of the Life Science Industry - PR Newswire
Cardiomatics Cooperates with the Biotronik Sales Organization in Germany to Accelerate the Growth of its Leading AI-powered ECG Analysis Solution in the German Market - Diagnostic and Interventional Cardiology
HeartSciences Announces Further Internationalization of its AI-ECG Patent Portfolio - GlobeNewswire
US Stocks Edge Higher; Applied Materials Posts Upbeat Earnings - Benzinga
HeartSciences’ MyoVista Wavelet Technology Now Protected in Canada - MPO-mag
HeartSciences Announces Grant of Fundamental Patent by the European Patent Office Covering Assessment of Diastolic Function of the Heart Using AI-ECG - Diagnostic and Interventional Cardiology
Partho Sengupta Joins HeartSciences’ Scientific Advisory Board - MPO-mag
HeartBeam Presents Positive Results on its Artificial Intelligence Capabilities for Detecting Arrhythmias - Diagnostic and Interventional Cardiology
Ensight-AI Awarded FDA’s Breakthrough Device Designation for Its ECGVision-TTR Technology for Early Detection of ATTR-Cardiomyopathy - Diagnostic and Interventional Cardiology
A Deep Dive into HeartSciences (HSCS): A Diamond in the Rough - DataDrivenInvestor
HeartSciences Appoints Dr. Partho P. Sengupta, MD, MBBS, FACC, to its Scientific Advisory Board - citybiz
1.79%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):